Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Injectable vs Oral Naltrexone for Alcohol Dependence in SMI
NCT00453804Phase 4Completed
- Sponsor
- Upstate Medical University
- Start
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of naltrexone in alcohol dependence (2 arms), sponsored by Upstate Medical University. Primary endpoints: Measures of Alcohol Use at 16 weeks and Psychiatric Symptom Severity at 16 weeks. Started Jul 2006; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00453804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00453804.